#AI Chips

Funding broadens AI-chip customers’ choices when it becomes deliverable systems and sustained orders.

With large rounds in hand, model companies are starting to spend like big tech: training their own models while using investments to hold a position in the next field.

AI compute contracts keep getting bigger, but the number that matters is whether they can be cancelled: that decides whether the risk ends up with the model company or the compute provider.

Flagship capability pushed down and prices cut in half — OpenAI has changed the unit of competition from model scores to cost per task.

Kimi K3 has lifted Moonshot's revenue velocity; its next valuation depends more on retention and inference margins than on the steepness of an ARR curve.

Microsoft has translated its 2032 compute demand into a 38-gigawatt construction plan, making energization speed a ceiling on cloud growth.

Competition in Chinese AI chips is moving from whether systems are available to the cost of delivery, with HBM transmitting prices through the stack.

A company whose valuation rose sevenfold in six months is queuing to list — pricing power is being handed from private markets to public ones.

When the usage tier cannot be explained, the loss is not the settlement — it is that people willing to pay $200 a month start comparison shopping.

On the robotics line, what Nvidia actually sells is the simulation toolchain; the chip is just its carrier.

A $7 billion acquisition failed while a $4 billion independent round did not — pricing power in custom silicon is moving back toward the seller.

The first-gen ASIC beats today's flagship GPU, and the win isn't about process node—it's the ability to put model, compiler, and silicon in the same iteration cycle.

The $2 trillion figure currently exists only in conversations between banks and investors; the company hasn't confirmed a word. The real pricing will happen on the day the prospectus discloses compute spending.

The $2 trillion figure is a psychological price point investors extrapolate from the revenue slope, and October's pricing window will test whether that slope can hold up in the public markets.

A company with no product is worth $10 billion — the price is set on the researcher himself, not the company.

The price war in mid-tier models has shifted from "who is cheaper" to "who is more stable"—stability itself has become a product advantage.

Google is handing the research banner back to its product lines, but that banner is leaving with a cohort of talent in tow.

Run the same model twice and the second pass adds 10 points—post-training is becoming a more valuable asset than parameter count.